Asian Spectator

.
Business Advice

.

Octa’s compelling Ramadan 2023—Memories which become templates for the future

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 27 March 2024 - It is time to recall all the Ramadan initiatives the international broker Octa has launched and curated throughout the last year. C...

Professional Fighters League Announces Deal With Mark Burnett ...

WASHINGTON, March 30, 2018 /PRNewswire-AsiaNet/ -- - PFL Appoints Mark Burnett to Advisory Board The Professional Fighters League (PFL), the world's only major mixed martial arts league, an...

Radiaction Medical Ltd. Receives FDA Clearance for its Innovat...

TEL AVIV, Israel, April 4, 2022 /PRNewswire-AsiaNet/ -- Radiaction Medical Ltd. [ http://www.radiactionmedical.com/] ("Radiaction"), an innovative medical device company focused on radiation...

Xiaozhu.com and agoda Announce Global Strategic Partnership to...

BEIJING, March 13, 2018 /PRNewswire-AsiaNet/-- China's leading and fastest growing house-sharing platform Xiaozhu.com has announced a global strategic partnership with global online booking ...

ZircoDATA Announces Acquisition in NSW and Appoints New CEO

MELBOURNE, VIC., Australia, Jan. 27, 2021 /PRNewswire-AsiaNet/-- ZircoDATA, a privately owned records and information management (RIM) company providing services throughout Australia, has co...

Hong Kong’s first survey on children’s sense of touch: Close to 70% of parents concerned about children’s stunted growth from deprivation of physical touch

Reckitt Benckiser and its brand Dettol promote Global Handwashing Day and support over 10,000 families in need to ‘Seize the Childhood and Keep On to Protect Our Future’HONG KONG...

US Tech Innovators Choose Montenegro Citizenship by Investment...

LONDON, October 19, 2021, /PRNewswire-AsiaNet/-- Henley & Partners [https://www.henleyglobal.com/ ] is reporting a sharp rise in interest in the Montenegro Citizenship by Investment Pro...

VeChain Announces A Market Ready Blockchain Food Safety Soluti...

SHANGHAI, Aug. 13, 2020 /PRNewswire-AsiaNet/ -- COVID-19 has accelerated the need for food companies to build more resilient and transparent supply chains to cope with the challenges from an...

BTS WORLD Original Soundtrack Album To Be Released Worldwide O...

SEOUL, South Korea, June 28, 2019 /PRNewswire-AsiaNet/ -- -- Music Video for Title Song "Heartbeat" Also Available on June 28-- Highly Anticipated BTS WORLD Mobile Game Becomes the No.1 Down...

Hitachi to Provide CNAO with Proton Therapy System

TOKYO, Dec 6, 2019 - (JCN Newswire) - Hitachi, Ltd. (TSE:6501) has entered into an agreement to provide Centro Nazionale di Adroterapia Oncologica (CNAO) with its proton therapy system.

image

Centro Nazionale di Adroterapia Oncologica (National Center for Oncological Hadrontherapy for the treatment of tumors)

In the comprehensive public tender process, Hitachi has been selected to provide proton therapy systems with the latest technologies including advanced scanning technology to irradiate even tumors with complex shapes with high precision.

The agreement includes multiyear service and maintenance of the system and this will be the 1st Hitachi Proton Therapy System to be installed in Italy and the 2nd in Europe.

CNAO, located in Pavia (near Milan), Italy, is a world's leading clinical center on particle cancer therapy and the first national hadrontherapy center in Italy. CNAO was established and is operated by the CNAO Foundation, a non-profit organization fully funded by the Italian government. CNAO has started cancer treatment for proton therapy since 2011 and heavy ion therapy since 2012, and it will develop a new proton therapy facility to enhance further research and cancer treatment.

Hitachi has been proactively promoting particle therapy system business worldwide, supplying world-class facilities with its highly reliable and proven particle therapy systems, which have treated more than 60,000 patients. Hitachi will provide system and services, including single room solution in realizing installation in urban limited areas and hybrid system combined with capability of generating both proton and heavy-ion in one accelerator, to meet all customer needs.

Hitachi will contribute to the improvement of people's quality of life and social values through the global expansion of its particle therapy system business.

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, is focusing on Social Innovation Business combining its operational technology, information technology and products. The company's consolidated revenues for fiscal 2018 (ended March 31, 2019) totaled 9,480.6 billion yen ($85.4 billion), and the company has approximately 296,000 employees worldwide. Hitachi delivers digital solutions utilizing Lumada in five sectors including Mobility, Smart Life, Industry, Energy and IT, to increase our customer's social, environmental and economic value. For more information on Hitachi, please visit the company's website at https://www.hitachi.com.

Copyright 2019 JCN Newswire. All rights reserved. www.jcnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

Disparitas pemidanaan: mengapa pelaku kekerasan seksual bisa mendapat hukuman berbeda-beda untuk kasus serupa?

Ilustrasi korban kekerasan seksual.Tinnakorn jorruang/ShutterstockPraktik hukum di Indonesia masih menunjukkan adanya disparitas pemidanaan, yakni ketika ada dua orang atau lebih melakukan tindak pida...

8 aspek penting untuk memastikan keberlanjutan industri nikel dari hulu ke hilir

Isu mengenai hilirisasi nikel Indonesia tengah panas beberapa tahun ke belakang. Ambisi Presiden Joko Widodo untuk menjadikan Indonesia sentra produksi baterai kendaraan listrik (EV) dunia membuat akt...

Gangguan dismorfik tubuh: apa yang perlu kita ketahui tentang kondisi kesehatan mental ini

Selebritas Megan Fox dalam sebuah wawancara dengan Sports Illustrated mengungkapkan bahwa dia memiliki dismorfik tubuh (body dysmorphia). Fox mengatakan: “Saya tidak pernah melihat diri saya sep...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion